Skip to main content
. 2022 Aug 3;13:950644. doi: 10.3389/fneur.2022.950644

Table 2.

Direct association between modifiable factors and cognitive trajectory subgroups, with reference to average performers *(N = 6,432).

Highest performers Lowest performer
(n = 2,298) (n = 642)
Relative RR
(95% CI)
P-value Relative RR
(95% CI)
P-value
Social/lifestyle factors
Education> 12 years 4.63 (4.07–5.29) <0.001 0.71 (0.59–0.85) <0.001
Living alone at home 0.89 (0.77–1.02) 0.09 1.26 (1.04–1.52) 0.02
Ever smoker 0.90 (0.79–1.03) 0.12 0.92 (0.76–1.11) 0.41
Ever alcohol intake 1.39 (1.17–1.66) <0.001 0.79 (0.63–0.99) 0.04
Chronic conditions
Hypertension 0.69 (0.60–0.80) <0.001 0.89 (0.72–1.10) 0.28
Dyslipidemia 1.06 (0.93–1.22) 0.36 1.30 (1.07–1.57) 0.007
Obesity 0.84 (0.73–0.97) 0.01 0.89 (0.73–1.09) 0.26
Diabetes 0.69 (0.56–0.86) 0.001 1.27 (0.98–1.64) 0.07
Pre-frailty/frailty 0.60 (0.52–0.68) <0.001 1.77 (1.47–2.14) <0.001
Depression 0.68 (0.54–0.85) 0.001 1.23 (0.94–1.60) 0.13
Chronic kidney disease 0.87 (0.75–1.01) 0.06 1.00 (0.83–1.21) 0.99

RR, risk ratio. * Compared to average performers (n = 3,492), and additionally adjusted for age, gender and ethnicity. (1) hypertension was defined as on treatment for high BP or BP > 140/90 mmHg at study entry; (2) dyslipidemia was defined as those taking cholesterol-lowering medications or serum cholesterol ≥212 mg/dL (≥5 mmol/L; Australia) and ≥240 mg/dL (≥6.2 mmol/L; U.S.) or LDL > 160 mg/dL (>4.1 mmol/L); (3) obesity was defined as body mass index ≥30; (4) diabetes was defined from self-report or fasting glucose ≥126 mg/dL (≥7 mmol/L) or on treatment for diabetes; (5) frailty was defined using the adapted Fried frailty criteria, including being underweight, weak grip strength, exhaustion, slow walking speed and low physical activity, with pre-frail including anyone with 1 or 2 criteria and Frail as anyone with three or more criteria (22); (6) depression was defined as CES-D-10 ≥8; (7) chronic kidney disease was defined as eGFR < 60 ml/min/1.73 m2 or urinary albumin to creatinine ratio ≥3 mg/mmol.